To combat AMR, we must be able to tell if TB is drug-resistant, have appropriate drugs to treat those infections, and develop vaccines to prevent infection. TB research & development must be recognized as a core component of an AMR response. #6MonthsMax bit.ly/2024AMRHLM

Earlier today, I led the ADPHA Uganda team to meet the health promotion team at the Ministry of Health ,we have had a very fruitful discusion on the inclusion of persons with disabilities in the national health campaigns on the prevention of HIV and TB in Uganda.

Erica Lessem of USAID's SMART4TB shares how important community engagement is needed across the research to policy process—from research agenda & priority setting ➡️ demand generation & adoption.

Toward a hep C vaccine: By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide. Cornell University College of Veterinary Medicine Cell Press news.cornell.edu/stories/2024/0…

An engagement between Ministry of Health and ADPHA _ UGANDA is underway to review IEC materials on TB and Leprosy disability inclusiveness at Lourdel Tower Upper Boardroom Kampala

Microarray Patches (MAPs) stick to your skin like a bandage and deliver drugs noninvasively through tiny microneedles. What do health advocates need to know about MAPs currently in the research pipeline? Read our FAQ: treatmentactiongroup.org/publication/fr…

'As a group, we oppose the cuts and we are actually demanding an expansion of that funding.' - ACT UP NY member + TAG Board President, Ivy Kwan Arce 👏👏👏

Tackling HCV-HIV comorbidity provides key opportunities for activist collaboration. TAG's HIV Project Director Riko Boone + HCV Project Director Joelle Dountio discussed leveraging advocacy surrounding each disease to end both pandemics @ TAG cosponsored SYNChronicity Conference.

.Danaher Corporation We are watching. You need to make the change #TimeFor5 #PeopleOverProfits

Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review link.springer.com/article/10.100… (open access) #HIV #PrEP

SMART4TB is hosting a webinar about the consensus process and statement for earlier inclusion of pregnant women and persons in TB research.
.
Register here: jhjhm.zoom.us/.../WN_N8AZkRK…

.HIV+Hepatitis Policy Institute’s Mike Knaapen led a meeting w/ congressional champion Senator Reverend Raphael Warnock for #HIV advocates to discuss the importance of fully funding domestic HIV programs to help #EndHIV in GA and across the US

This is insane. Cepheid believes in timely access for better patient care! So many people with drug-resistant TB won’t be able to access the right treatment on time largely because these two corporations keep the price high.

AMR is a major problem in TB, partially due to a lack of funding for TB treatment and R&D new for improved cures & vaccines. At the #2024AMRHLM let’s advocate to reach $22 billion in annual funding for TB that was agreed at the last TB HLM. #6MonthsMax bit.ly/2024AMRHLM

SAVE THE DATE: On June 20 @ 9 a.m. EST, TAG + fellow members of the SMART4TB consortium are hosting a webinar on the inclusion of pregnant people in TB research. Captions will be available in French, Spanish, Portuguese, and Russian. Register here: jhjhm.zoom.us/webinar/regist…

Today is HIV Long-Term Survivors Awareness Day ( #HLTSAD ), which 'celebrates the resiliency of long-term survivors living with #HIV and highlights their journeys and challenges'!

Learn more and access free resources from HIV.gov:
hiv.gov/blog/resources…

It's HIV Long-Term Survivors Awareness Day! We love this resource from The Well Project outlining key health and quality of life issues relevant to long-term survivors: thewellproject.org/hiv-informatio…

#HLTSAD

In the U.S. today, there are about 300,000 long-term survivors living with HIV. Learn how you can advocate for a higher quality of life for all long-term survivors: hiv.gov/events/awarene… #HLTSAD #Mobilize2Thrive

Impact of hormonal therapy on #HIV -1 immune markers in cis women and gender minorities onlinelibrary.wiley.com/doi/10.1111/hi… (open access) HIV Medicine

Drug-resistant TB is one of the deadliest forms of antimicrobial resistance (AMR), but is too often left out of discussions on AMR response. United Nations HLM offers opportunity to change that - let's fund DR-TB R&D! Read TAG's statement to multistakeholder hearing: treatmentactiongroup.org/letter/tag-com…